Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
---|
09/12/2013 | WO2013133472A1 Activating transcription factor 3 (atf3) for toxicity prediction and as therapeutic target |
09/12/2013 | WO2013133459A1 Reagent composition for biosensors and biosensor comprising reagent layer formed of the same |
09/12/2013 | WO2013133402A1 Method for detecting single nucleotide polymorphism in nucleic acid |
09/12/2013 | WO2013133393A1 Single-stranded nucleic acid molecule for inhibiting vegf gene expression |
09/12/2013 | WO2013133351A1 Novel fgfr3 fusion product |
09/12/2013 | WO2013133330A1 Plant having suppressed expression of glycoalkaloid biosynthetic enzyme gene or altered activity of the enzyme |
09/12/2013 | WO2013133298A1 Method for detecting inflammatory bowel disease, and method for testing human salivary flora |
09/12/2013 | WO2013133297A1 Method for stimulating t cell and use thereof |
09/12/2013 | WO2013133244A1 High speed gene amplification detection device |
09/12/2013 | WO2013133243A1 Juvenile hormone epoxidase gene and use thereof |
09/12/2013 | WO2013133220A1 Cancer malignancy testing method, pluripotent tumorigenic cells, and preparation method therefor |
09/12/2013 | WO2013133132A1 Method for producing double-stranded dna |
09/12/2013 | WO2013132700A1 Method for detecting target nucleic acid |
09/12/2013 | WO2013132645A1 Nucleic acid amplification method |
09/12/2013 | WO2013132504A1 Assay for the detection of nucleotide substitutions in genomes of sabin oral poliovirus vaccine viruses |
09/12/2013 | WO2013132502A1 Method and kit for the detection of hepatitis-specific antibodies |
09/12/2013 | WO2013132496A1 Methods and kits for the detection of viral infections |
09/12/2013 | WO2013132447A1 Real time pcr detection of m. tuberculosis resistant/susceptible to rifampicin and/or isoniazid |
09/12/2013 | WO2013132443A1 Real-time pcr detection of mycobacterium tuberculosis complex |
09/12/2013 | WO2013132412A1 Use of rbm39 as a biomarker |
09/12/2013 | WO2013132305A1 Size-based analysis of fetal dna fraction in maternal plasma |
09/12/2013 | WO2013132074A2 A genotyping test for assessing risk of autism |
09/12/2013 | WO2013132058A1 Diagnostic chewing gum for pathogens |
09/12/2013 | WO2013132025A1 Mirna based treatment monitoring in multiple sclerosis |
09/12/2013 | WO2013132001A1 Prognostic biomarkers for survival after treatment of a cancer disease with radiotherapy and/or chemotherapy |
09/12/2013 | WO2013131991A1 Means and methods for determining neurotoxin activity based on a modified luciferase |
09/12/2013 | WO2013131981A1 Predictive markers useful in the diagnosis and treatment of fragile x syndrome (fxs) |
09/12/2013 | WO2013131962A1 Improved methods of nucleic acid sequencing |
09/12/2013 | WO2013131933A1 In vitro method for determining disease outcome in pulmonary carcinoids |
09/12/2013 | WO2013131888A1 Cyclic single molecule sequencing process |
09/12/2013 | WO2013131885A1 Compatible solute ectoine as well as derivatives thereof for enzyme stabilization |
09/12/2013 | WO2013131567A1 Mirna based treatment monitoring in multiple sclerosis |
09/12/2013 | WO2013131411A1 Micro-devices for improved disease detection |
09/12/2013 | WO2013131235A1 Two-photon fluorescent probe using naphthalene as matrix and preparation method and use thereof |
09/12/2013 | WO2013131143A1 Micrornas and uses thereof |
09/12/2013 | WO2013131130A1 Organic thin film transistors and the use thereof in sensing applications |
09/12/2013 | WO2013107460A3 Micrornas for prediction of treatment efficacy and prognosis of cancer patients |
09/12/2013 | WO2013098797A3 Diagnostic tests for predicting prognosis, recurrence, resistance or sensitivity to therapy and metastatic status in cancer |
09/12/2013 | WO2013070796A3 Propeptide-luciferase fusion proteins and methods of use thereof |
09/12/2013 | WO2013067489A9 Nucleic acid-based linkers for detecting and measuring interactions |
09/12/2013 | WO2013006720A3 Optimized probes and primers and methods of using same for the binding, detection, differentiation, isolation and sequencing of influenza a; influenza b and respiratory syncytial virus |
09/12/2013 | WO2012096873A9 Methods and drug products for treating alzheimer's disease |
09/12/2013 | WO2012078618A3 Predicting and treating diabetic complications |
09/12/2013 | US20130239239 Lmcd1 cancer markers and methods for their use |
09/12/2013 | US20130239234 Phosphodiesterase activity and regulation of phosphodiesterase 1b-mediated signaling in brain |
09/12/2013 | US20130237696 Vascular therapeutics |
09/12/2013 | US20130237588 Vascular therapeutics |
09/12/2013 | US20130237586 DELIVERY OF dsRNA TO ARTHROPODS |
09/12/2013 | US20130237520 Imidazopyrazine syk inhibitors |
09/12/2013 | US20130237460 Sensor circuit for controlling, detecting, and measuring a molecular complex |
09/12/2013 | US20130237457 Method of detecting pathogenic legionella strains |
09/12/2013 | US20130237456 Marker consisting of plasma microrna and a new method for diagnosis of hepatocellular carcinoma |
09/12/2013 | US20130237451 Compositions and methods for treatment of protein misfolding diseases |
09/12/2013 | US20130237450 Method for Detecting Nucleic Acids |
09/12/2013 | US20130237449 Usp2a peptides and antibodies |
09/12/2013 | US20130237448 Sugarcane-sugar-yield-related marker and the use thereof |
09/12/2013 | US20130237447 Genetic markers associated with scoliosis and uses thereof |
09/12/2013 | US20130237446 Use of the Genes in the Hog, Ras and cAMP Pathway for Treatment Of Fungal Infection |
09/12/2013 | US20130237445 Methods and kits for detecting melanoma |
09/12/2013 | US20130237444 Gbm molecular contexts associated with patient survival |
09/12/2013 | US20130237442 Methods and Compositions for Diagnosis of Non-Viable Early Pregnancy |
09/12/2013 | US20130237441 Mig-6 Knockout Mice and Elucidation of Association of Mig-6 With Early Onset Degenerative Joint Disease and Role As A Tumor Suppressor |
09/12/2013 | US20130237440 Method and means for identification of animal species |
09/12/2013 | US20130237438 Physiogenomic method for predicting statin injury to muscle and muscle side effects |
09/12/2013 | US20130237437 Nucleic acid hybridization probes |
09/12/2013 | US20130237434 Separation of pyrophosphate release and pyrophosphate detection |
09/12/2013 | US20130237432 Application of a pcr sequencing method, based on dna barcoding technique and dna incomplete shearing strategy, in hla genotyping |
09/12/2013 | US20130237431 Size-based analysis of fetal dna fraction in maternal plasma |
09/12/2013 | US20130237429 Discovery and utilization of sorghum genes (ma5/ma6) |
09/12/2013 | US20130237428 Methods for high level multiplexed polymerase chain reactions and homogeneous mass extension reactions |
09/12/2013 | US20130237427 Y-shaped probe and variant thereof, and dna microarray, kit and genetic analysis method using the same |
09/12/2013 | US20130236925 Detection of rate changes in systematic oscillations of metabolic pathways by monitoring isotope ratios |
09/12/2013 | US20130236920 Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of dna |
09/12/2013 | US20130236905 Assay for identifying antigens that activate b cell receptors comprising neutralizing antibodies |
09/12/2013 | US20130236904 Method for screening for materials for promoting the differentiation of skin cells |
09/12/2013 | US20130236901 Microfluidic device for production and collection of droplets of a fluid |
09/12/2013 | US20130236898 Anaplasma FAMILY MEMBERS CAUSE A NUMBER OF BLOOD-BORNE DISEASES |
09/12/2013 | US20130236897 Anaplasma FAMILY MEMBERS CAUSE A NUMBER OF BLOOD-BORNE DISEASES |
09/12/2013 | US20130236896 E. coli o157:h7 specific assay |
09/12/2013 | US20130236895 Method of sequence determination using sequence tags |
09/12/2013 | US20130236894 Mutations in sptlc2 gene associated with sensory neuropathy |
09/12/2013 | US20130236893 Method of detecting type ii diabetes |
09/12/2013 | US20130236892 Means and methods for the detection of a predisposition of a female subject to recurrent pregnancy loss (rpl), preeclampsia (pe) and/or fetal growth restriction (fgr) |
09/12/2013 | US20130236891 Method and composition for the treatment, prevention, and diagnosis of cancer containing or derived from cancer stem cells |
09/12/2013 | US20130236890 Novel method for analyzing circulating tumor cells of a patient for the presence of metastasis-initiating cells |
09/12/2013 | US20130236886 Phage Phi 29 DNA Polymerase Chimera |
09/12/2013 | US20130236884 Compositions for use in identification of orthopoxviruses |
09/12/2013 | US20130236883 Process of directly detecting and identifying a microorganism in a biological sample diluted in an enrichment broth |
09/12/2013 | US20130236880 Direct detection of unamplified hepatitis c virus rna using unmodified gold nanoparticles |
09/12/2013 | US20130236567 Gene expression signature as a predictor of chemotherapeutic response in breast cancer |
09/12/2013 | US20130236566 Red Blood Cell Dynamics for Diagnosis |
09/12/2013 | US20130236484 Leishmaniasis antigen detection assays and vaccines |
09/12/2013 | US20130236465 Epidermal growth factor receptor variant lacking exon |
09/12/2013 | US20130236450 Methods Using Lipoprotein-Associated Phospholipase A2 in an Acute Care Setting |
09/12/2013 | US20130236441 Methods of treating and preventing thrombotic diseases using ask1 inhibitors |
09/12/2013 | US20130236437 Compositions, kits and methods for treatment of cardiovascular, immunological and inflammatory diseases |
09/12/2013 | US20130236404 Substances and compositions for enhancing dna repair and methods of use |
09/12/2013 | US20130233726 Method of correcting for oxygen effect on test sensors |
09/12/2013 | DE102012101885A1 Determining catalytic activity of molecules, involves providing active molecule with biological deiodinase activity, providing substrate compound for molecule, and contacting reaction partners with molecule and substrate under conditions |
09/12/2013 | CA2861054A1 Compatible solute ectoine as well as derivatives thereof for enzyme stabilization |